Device Trial Radar · NCT06578104
PULSED AF Post-Approval Study
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
580
Planned (sponsor's estimate)
Start
Nov 4, 2024
Primary completion
Apr 30, 2027
Study completion Apr 30, 2030
Sponsor
- Lead sponsor
- Medtronic Cardiac Ablation SolutionsPublic (MDT)
- Sponsor type
- Industry
- First posted
- Aug 29, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.
Conditions
- Atrial Fibrillation
Interventions
PulseSelect™ PFA systemDevice
Ablation using the PulseSelect™ PFA system
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy-Freedom from Atrial FibrillationTime frame: 36-months after the index ablation procedure
- Safety- Freedom from Device/Procedure Related Adverse EventsTime frame: 6 months post-ablation]
Locations
29 sites in 3 countries. Site status is shown where the registry gives one.
Huntsville Hospital
Huntsville, Alabama · Recruiting
Clermont- Ambulatory Surgical Center
Clermont, Florida · Recruiting
University of South Florida Health (USF)
Tampa, Florida · Terminated
26 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.